By: Emily MacHale
Tustin, CA – Integrium, LLC Executives are attending the 2017 MassBio Annual Meeting in Boston, MA on March 30 – 31, 2017. Each year, the Integrium team is happy to be a part of the fast-paced program the Massachusetts Life Sciences industry offers.
“We are always excited to watch the Massachusetts biotechnology ecosystem engage in keynote presentations, discussions, workshops, networking meetings, and more,” states Michael Loftus, Executive Director of Business Development.
With the number of topics the meeting provides, Integrium especially looks forward to discussions around biotechs funding and emerging markets. As Integrium helps biotechnology, medical device, and diagnostic companies attain clinical data to raise their next round of capital, learning more about the funding industry is a major benefit to Integrium Executives. It is always a pleasure learning from industry experts, keynote speakers, and special guests on their view of our everchanging biotech ecosystem.
Integrium Executives will be available for meetings throughout MassBio at varying times and locations. Details are upon meeting request. To reserve a timeslot to meet with Integrium, click to register below or contact Emily MacHale at Emily.MacHale@integrium.com.
Integrium helps Micro Cap, Small Cap, and Privately held Biotechs within the Generic and Innovator space attain clinical data so they can raise the next round of capital. lntegrium's areas of therapeutic focus include Cardiovascular, Metabolic, Renal, Inflammatory, Dermatology, Wound Healing, Gene Therapy, and Orphan Diseases. Secondary specialties include Schedule 2 drugs and Oncology
To learn more about Integrium, contact:
Associate Director of Marketing & Research